Articles with "serous cystadenocarcinoma" as a keyword



Photo from wikipedia

Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma

Sign Up to like & get
recommendations!
Published in 2023 at "Stem Cells International"

DOI: 10.1155/2023/4500561

Abstract: Ovarian serous cystadenocarcinoma (OV) is a fatal gynecologic cancer with a five-year survival rate of only 46%. Resistance to platinum-based chemotherapy is a prevalent factor in OV patients, leading to increased mortality. The platinum resistance… read more here.

Keywords: stem cell; serous cystadenocarcinoma; stem; ovarian serous ... See more keywords
Photo by kellysikkema from unsplash

Inferences of carboplatin response-related signature by integrating multiomics data in ovarian serous cystadenocarcinoma

Sign Up to like & get
recommendations!
Published in 2022 at "Experimental Biology and Medicine"

DOI: 10.1177/15353702221083254

Abstract: Platinum-based chemotherapy, especially carboplatin, is the primary measure to treat patients with ovarian cancer (OC). However, OC patients still have an adverse prognosis due to emergency of chemotherapy resistance. Ovarian serous cystadenocarcinoma (OSC) is the… read more here.

Keywords: carboplatin response; signature; serous cystadenocarcinoma; resistance ... See more keywords
Photo by leirenestrong from unsplash

FBXW7γ is a tumor-suppressive and prognosis-related FBXW7 transcript isoform in ovarian serous cystadenocarcinoma.

Sign Up to like & get
recommendations!
Published in 2020 at "Future oncology"

DOI: 10.2217/fon-2020-0371

Abstract: Aim: To explore FBXW7 protein-coding transcript isoform (α, β and γ) expression, their functions and prognostic value in ovarian serous cystadenocarcinoma (OSC). Materials & methods: FBXW7 transcript data were collected from The Cancer Genome Atlas… read more here.

Keywords: ovarian serous; transcript isoform; fbxw7 transcript; serous cystadenocarcinoma ... See more keywords
Photo from wikipedia

TRPs in Ovarian Serous Cystadenocarcinoma: The Expression Patterns, Prognostic Roles, and Potential Therapeutic Targets

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Molecular Biosciences"

DOI: 10.3389/fmolb.2022.915409

Abstract: Ovarian cancer (usually ovarian serous cystadenocarcinoma, or OV) is the fifth leading cause of cancer-related deaths in women, with more than 184,000 deaths reported worldwide annually, and is a highly malignant carcinoma. However, the mechanism… read more here.

Keywords: expression; serous cystadenocarcinoma; analysis; ovarian serous ... See more keywords
Photo from wikipedia

Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma

Sign Up to like & get
recommendations!
Published in 2017 at "Oncology Reports"

DOI: 10.3892/or.2017.5517

Abstract: Yes-associated protein 1 (YAP1) is a key transcriptional regulator in the Hippo signaling pathway that plays a critical role in the development and progression of several types of malignancies, including ovarian cancer. Herein, we investigated… read more here.

Keywords: associated protein; ovarian serous; serous cystadenocarcinoma; expression ... See more keywords